Ann Clin Neurophysiol.  2017 Jan;19(1):64-67. 10.14253/acn.2017.19.1.64.

Guillain-Barre syndrome after generalized tetanus infection

Affiliations
  • 1Department of Neurology, Wonkwang University School of Medicine, Institute of Wonkwang Medical Science and Regional Cardiocerebrovascular Center, Iksan, Korea. hypppark@hanmail.net
  • 2Department of Internal Medicine, Wonkwang University School of Medicine, Iksan, Korea.

Abstract

Guillain-Barre syndrome (GBS) is an auto-immune disease of peripheral nerve system. It occurs mainly after preceding infection such as upper respiratory or gastrointestinal infection and other antecedent events as tetanus vaccinations. However, any case of GBS after tetanus infection has not been reported. Recently, when analyzed the clinical aspects of 13 tetanus patients including ours, 2 GBS occurred after tetanus infection. We report the neurological and electrophysiologic findings of two cases of Guillain-Barre Syndrome after generalized tetanus.

Keyword

Autoimmune diseases; Guillain-Barre syndrome; Tetanus

MeSH Terms

Autoimmune Diseases
Guillain-Barre Syndrome*
Humans
Peripheral Nerves
Tetanus*
Vaccination

Reference

1.Park SS., Noh Y., Oh SH., Hong YH., Park SH. Guillain-Barre syndrome with anti-GM1 and GD1b antibodies following acute hepatitis A. J Korean Neurol Assoc. 2008. 26:379–382.
2.Kongbunkiat K., Kasemsap N., Tiamkao S., Sawanyawisuth K. Clinical manifestations and outcomes of Guillain-Barré syndrome after diphtheria and tetanus vaccine (dT) during a diphtheria outbreak in Thailand: a case series. Neurology Asia. 2014. 19:149 -155.
3.Kang J., Bae HJ., Kim BK., Koo JS., Park JM., Kim HJ, et al. Guil-lian-Barre syndrome after preceding shingles. J Korean Neurol Assoc. 2006. 24:270–273.
4.Go JY., Seok JI., Do Y. Guillain-Barre syndrome following acute ce-rebral infarction. J Korean Neurol Assoc. 2014. 32:269–271.
5.Lahbabi M., Ghissassi M., Belahcen F., Ibrahimi SA., Aqodad N. Acute inflammatory demyelinating polyneuropathy after treatment with pegylated interferon alfa-2a in a patient with chronic hepatitis C virus infection: a case report. J Med Case Rep. 2012. 6:278.
Article
6.Pritchard J., Mukherjee R., Hughes RA. Risk of relapse of Guil-lain-Barré syndrome or chronic inflammatory demyelinating polyradiculoneuropathy following immunization. J Neurol Neurosurg Psychiatry. 2002. 73:348–349.
7.Lee JH., Hwang YS., Cho JH. Generalized tetanus could be com-plicated with Guillian-Barré syndrome. Int J Infect Dis. 2016. 48:20–21.
8.Hassel B. Tetanus: Pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms. Toxins (Basel). 2013. 5:73–83.
Article
9.Csurhes PA., Sullivan AA., Green K., Greer JM., Pender MP., Mc-Combe PA. Increased circulating T cell reactivity to GM1 gangli-oside in patients with Guillain-Barré syndrome. J Clin Neurosci. 2005. 12:409–415.
Article
10.Kim CH., Seo HJ., Cha MJ., Kim MJ., Minn YK., Cho SJ, et al. Electro-physiological tests in generalized tetanus. J Korean Neurol Assoc. 2007. 25:33–37.
11.Bolton CF., Laverty DA., Brown JD., Witt NJ., Hahn AF., Sibbald WJ. Critically ill polyneuropathy: electrophysiological studies and differentiation from Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 1986. 49:563–573.
Full Text Links
  • ACN
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr